Skip to the main content

Liječnički vjesnik, Vol. 142 No. Supp 5, 2020.

Meeting abstract

https://doi.org/10.26800/LV-142-supp5-14

The use of cladribine in the treatment of multiple sclerosis

Nikola Erceg ; School of Medicine, University of Zagreb, Croatia
Anamaria Dukić ; School of Medicine, University of Zagreb, Croatia
Tereza Gabelić ; School of Medicine, University of Zagreb, Croatia

Full text: english pdf 176 Kb

downloads: 199

cite

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system. The cause of MS is still unknown, but it is considered to be multifactorial. A combination of clinical examination, radiological, and laboratory methods according to the McDonald diagnostic criteria confirms the diagnosis with high probability. Management of MS includes disease-modifying drugs that show different levels of efficacy. Cladribine is an antimetabolite drug indicated for the treatment of highly active relapsing-remitting MS based on clinical or imaging features.

Keywords

Cladribine; Lymphocyte count; Multiple sclerosis

Hrčak ID:

251653

URI

https://hrcak.srce.hr/251653

Publication date:

27.1.2021.

Visits: 688 *